📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Norfluoxetine inhibits TREK-2 K2P channels by multiple mechanisms including state-independent effects on the selectivity filter gate. (2021)

First Author: Proks P

Attributed to: Exploitation of a Pharmacological 'Master Switch' to Probe the K+ Channel Selectivity Filter Gating Mechanism funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1085/jgp.202012812

PubMed Identifier: 34032848

Publication URI: http://europepmc.org/abstract/MED/34032848

Type: Journal Article/Review

Volume: 153

Parent Publication: The Journal of general physiology

Issue: 8

ISSN: 0022-1295